Recurrent Visceral Leishmaniasis in a Case With Interleukin-12 Receptor Beta-1 Deficiency

Hatice Uygun1, Ayse Ceyda Oren2, Esra Pekpak Sahinoglu2

  • 1Department of Pediatric Infectious Disease, Gaziantep University School of Medicine, Gaziantep, Turkey. ozhanhatice@hotmail.com.

Acta Parasitologica
|October 10, 2024
PubMed

Insights

Interleukin-12 receptor beta 1 (IL-12Rβ1) deficiency can cause recurrent visceral leishmaniasis (VL) in children. Immunological evaluation is crucial for patients with VL to identify potential IL-12Rβ1 defects.

Area of Science:

  • Immunology
  • Genetics
  • Infectious Diseases

Background:

  • Interleukin-12 receptor beta 1 (IL-12Rβ1) deficiency is a rare genetic disorder.
  • It is characterized by susceptibility to infections, particularly from mycobacteria and Salmonella.

Observation:

  • A pediatric patient with recurrent visceral leishmaniasis (VL) was diagnosed with IL-12Rβ1 deficiency.
  • The patient developed VL at 91 months after BCG vaccination.

Findings:

  • IL-12Rβ1 deficiency is linked to mutations in the IFN-γ/IL-12 pathway.
  • This genetic defect predisposes individuals to recurrent Leishmania infections.

Implications:

  • This case highlights IL-12Rβ1 deficiency as a potential cause of VL.
  • Immunological assessment is recommended for VL patients to detect underlying immune defects.
Abstract